xylometazoline has been researched along with Cardiomyopathies in 1 studies
xylometazoline: RN given refers to parent cpd; structure
Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Figueiras-Graillet, LM | 1 |
| Martínez-Sellés, M | 1 |
| Perez-David, E | 1 |
| Fernandez-Avilés, F | 1 |
1 other study available for xylometazoline and Cardiomyopathies
| Article | Year |
|---|---|
Reversible cardiomyopathy due to chronic use of xylometazoline topical nasal spray.
Topics: Administration, Inhalation; Administration, Topical; Adrenergic alpha-Agonists; Cardiomyopathies; Hu | 2013 |